| Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma : a case report | Haematologica |  | | 2026 | 11 | 45 |
|
| Targeting ferritinophagy to iron out Tet2-mutant cells | Blood | | | 2025 | 3 | 8 |
|
| Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemia | Communications biology | | | 2025 | 3 | 5 |
|
| The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia | Blood advances | | | 2025 | 79 | 202 |
|
| Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies : an observational nationwide cohort study | The lancet. Haematology | | | 2024 | 3 | 21 |
|
| Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B-cell lymphoma : Insights from real-life clinical practice | Cancer reports | | | 2024 | 73 | 577 |
|
| Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation | Leukemia | | | 2024 | 39 | 41 |
|
| Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models | Science translational medicine |  | | 2024 | 190 | 0 |
|
| Selective haematological cancer eradication with preserved haematopoiesis | Nature | | | 2024 | 156 | 108 |
|
| AMPK activation induces immunogenic cell death in AML | Blood advances | | | 2023 | 82 | 35 |
|
| Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia | Blood advances | | | 2023 | 180 | 364 |
|
| Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia | Leukemia | | | 2023 | 82 | 148 |
|
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma | Cell death and disease | | | 2023 | 328 | 234 |
|
| An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML | Cancer discovery | | | 2022 | 369 | 377 |
|
| RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia | Leukemia | | | 2022 | 146 | 75 |
|
| T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | | | 2022 | 266 | 151 |
|
| AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia | Cancers | | | 2021 | 212 | 98 |
|
| Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia | Science advances | | | 2015 | 214 | 282 |
|
| The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation | Blood | | | 2010 | 228 | 630 |
|
